Apcotex Industries Q1FY27 profit up 312% on 40% sales

Key takeaway from the quarter

Apcotex Industries reported a sharp improvement in profitability for the quarter ended June 30, 2026 (Q1FY27), supported by stronger revenue and a steep expansion in operating margins. Net profit rose 312% year-on-year to ₹789.4 million, while revenue from operations increased 40% to ₹5,256.3 million. EBITDA more than tripled to ₹1,177.6 million, reflecting a materially higher margin profile compared with the year-ago period. The company also attributed part of the margin improvement to favourable inventory changes. The results were presented as audited financial results and were approved by the Board of Directors on July 29, 2026. The financial statements were reviewed by the Audit Committee before board approval.

Q1FY27 numbers at a glance

The company’s Q1FY27 performance stood out primarily on two metrics: profit growth and margin expansion. EBITDA margin expanded to 22.4% from 10.3% in Q1FY26, a rise of 1,210 basis points, according to the disclosed figures. Earnings per share (basic and diluted) increased in line with profits to ₹15.23 from ₹3.70. Revenue growth remained strong at 40% year-on-year, indicating higher business activity versus the prior-year quarter. The combination of higher revenue and better margins flowed through to net profit after tax. The numbers were shared as part of the quarterly audited disclosure.

Detailed financial performance table

What supported margins this quarter

Apcotex Industries indicated that EBITDA margin expansion was aided by favourable inventory changes. The disclosed margin movement, from 10.3% to 22.4%, suggests a significantly stronger operating outcome compared with the year-ago base. With EBITDA at ₹1,177.6 million on revenue of ₹5,256.3 million, operating profitability improved far faster than topline growth. The quarter also showed a sharp year-on-year jump in EBITDA of 205%, which is well ahead of the 40% increase in revenue. That gap is consistent with the reported margin step-up. The company has not detailed additional line-item drivers in the provided information beyond inventory-related benefits.

Board approval and audit confirmation

The Board of Directors approved the audited financial results on July 29, 2026, following a review by the Audit Committee. The results were certified by Manubhai & Shah LLP, the statutory auditor. The auditor confirmed that the results present a true and fair view and are compliant with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure also references compliance with Indian Accounting Standards (Ind AS). Such certifications are a standard requirement for listed entities but are particularly relevant in quarters where profitability moves sharply, as they reinforce the integrity of reported numbers.

Earnings call: date, time, and access details

Apcotex announced an earnings conference call scheduled for July 30, 2026 at 2:00 PM IST to discuss performance for the quarter ended June 30, 2026. The session is set to feature Vice Chairman and Managing Director Abhiraj Choksey and CFO Vivek Thakur. Investors and analysts can join via dial-in numbers or through an online access option (Diamond Pass link was referenced). The company has indicated multiple participation channels to broaden access. These calls typically focus on business drivers, demand conditions, pricing, and capacity utilisation, although no agenda beyond Q1FY27 performance review was specified.

Operating context: volumes, utilisation, and growth commentary

In commentary included with the provided material, the company cited strong volume growth of 14% in FY26 and said it expects volumes to continue growing. It also indicated an expectation of double-digit volume growth for FY27, potentially in the low double-digits if demand sustains and capacity is available. Capacity utilisation was described as reaching 90%-100% in Q4, with earlier quarters seeing lower utilisation. While these remarks are not presented as Q1FY27-specific metrics, they frame management’s view of demand and operational constraints. For investors, volume trajectory and utilisation levels matter because they can influence fixed-cost absorption and margins.

Capital expenditure and capacity expansion plans

The provided information also references board-approved investments of ₹2,100 million for capacity expansion at the Valia facility. Separately, management commentary cited an expected total capex of about ₹650 million for a year, with around ₹200 million to ₹250 million earmarked for expansion projects and the balance expected to occur in the following year and potentially spill over into FY27-28. These figures indicate that capacity and operational readiness remain a focus area. The timeline reference of “six quarters” was also mentioned in the material, without additional project specifics. Investors tracking execution will typically watch for utilisation, commissioning milestones, and any impact on working capital.

Market snapshot and what investors will track next

The stock information in the provided text shows a price of ₹529, a P/E ratio of 25.1, and a market capitalisation of ₹2,532 crore (₹25,320 million). It also notes that the company currently shows a “below-average growth signal,” without further methodology details. Following a quarter with large profit expansion, the next key datapoints for the market will likely be management’s commentary on sustainability of margins, inventory effects, demand conditions, and capacity availability. The July 30, 2026 earnings call is the next scheduled event where investors can seek clarity directly from management. Any additional disclosures or updates shared through stock exchanges after the call will be closely read for confirmations around volumes and capex execution.

Conclusion

Apcotex Industries delivered a strong Q1FY27 outcome, with net profit rising to ₹789.4 million on revenue of ₹5,256.3 million and EBITDA margin expanding to 22.4%. The audited results were approved by the board on July 29, 2026 and certified by the statutory auditor as compliant with SEBI’s listing regulations and Ind AS. The immediate next milestone is the earnings conference call on July 30, 2026 at 2:00 PM IST, where investors will look for more detail on margin drivers, volume outlook, and capacity-related plans.